SIMILAR MARKET STUDIES
Summary Glenmark Generics Limited (GGL) is a pharmaceutical company. The company develops, manufactures, markets and distributes generic finished dosage forms and active pharmaceutical ingredients. GGL products include oxcarbazepine, gabapentin, hydroxyzine, antihistamine, naproxen, pravastatin sodium, topiramate, amiodarone, telmistartan, esomeprazole magnesium, lornoxicam, linezolid, and perindopril erbumine, among others. The company distributes products through ...
October 2014 | $300 | View Details >>
Notes: Production, means the output of Autoimmune Disease Therapeutics Revenue, means the sales value of Autoimmune Disease Therapeutics This report studies Autoimmune Disease Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share ...
February 2017 | $2900 | View Details >>
ICD Research's 'Grupo Casa Saba, S.A.B. de C.V.: Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, financial ratios, details of locations and subsidiaries, plus information on key news events affecting the company.
October 2011 | $99 | View Details >>
Summary Spectrum Pharmaceuticals, Inc., (Spectrum Pharmaceuticals), formerly, NeoTherapeutics, Inc., is an integrated biotechnology company. It carries out the acquisition, development, and commercialization of diverse pipeline of late-stage clinical and commercial products with particular focus on oncology. The company markets four drugs, namely, Fusilev, Folotyn, Zevalin and Marqibo. It has three drugs ...
May 2014 | $250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research